{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T02:06:35Z","timestamp":1781834795898,"version":"3.54.5"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100011700","name":"National Medicinal Plants Board, Ministry of AYUSH, Government of India","doi-asserted-by":"publisher","award":["Z. 18017\/187\/CSS\/R&D\/DL-01\/2019-20-NMPB-IVA"],"award-info":[{"award-number":["Z. 18017\/187\/CSS\/R&D\/DL-01\/2019-20-NMPB-IVA"]}],"id":[{"id":"10.13039\/501100011700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s11010-021-04120-6","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T13:28:22Z","timestamp":1615296502000},"page":"2739-2752","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mechanistic insights into the pathogenesis of neurodegenerative diseases: towards the development of effective therapy"],"prefix":"10.1007","volume":"476","author":[{"given":"Fauzia","family":"Nazam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibhghatulla","family":"Shaikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazia","family":"Nazam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz Saad","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulam Mustafa","family":"Hasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3663-4940","authenticated-orcid":false,"given":"Md.Imtaiyaz","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"4120_CR1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/YCO.0b013e32834bb9d4","volume":"24","author":"D Enache","year":"2011","unstructured":"Enache D, Winblad B, Aarsland D (2011) Depression in dementia: epidemiology, mechanisms, and treatment. Curr Opin Psychiatry 24:461\u2013472","journal-title":"Curr Opin Psychiatry"},{"key":"4120_CR2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0272-7358(99)00062-8","volume":"20","author":"J Kasl-Godley","year":"2000","unstructured":"Kasl-Godley J, Gatz M (2000) Psychosocial interventions for individuals with dementia: an integration of theory, therapy, and a clinical understanding of dementia. Clin Psychol Rev 20:755\u2013782","journal-title":"Clin Psychol Rev"},{"key":"4120_CR3","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ejmech.2016.07.054","volume":"124","author":"V Kumar","year":"2016","unstructured":"Kumar V, Sami N, Kashav T, Islam A, Ahmad F, Hassan MI (2016) Protein aggregation and neurodegenerative diseases: from theory to therapy. Eur J Med Chem 124:1105\u20131120","journal-title":"Eur J Med Chem"},{"key":"4120_CR4","doi-asserted-by":"crossref","first-page":"e10248","DOI":"10.15252\/emmm.201810248","volume":"11","author":"S Voet","year":"2019","unstructured":"Voet S, Srinivasan S, Lamkanfi M, van Loo G (2019) Inflammasomes in neuroinflammatory and neurodegenerative diseases. EMBO Mol Med 11:e10248","journal-title":"EMBO Mol Med"},{"key":"4120_CR5","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/S1474-4422(18)30355-7","volume":"17","author":"WA Rocca","year":"2018","unstructured":"Rocca WA (2018) The burden of Parkinson\u2019s disease: a worldwide perspective. Lancet Neurol 17:928\u2013929","journal-title":"Lancet Neurol"},{"key":"4120_CR6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/sctm.19-0248","volume":"9","author":"B Srinageshwar","year":"2020","unstructured":"Srinageshwar B, Petersen RB, Dunbar GL, Rossignol J (2020) Prion-like mechanisms in neurodegenerative disease: implications for Huntington\u2019s disease therapy. Stem Cells Transl Med 9:559\u2013566","journal-title":"Stem Cells Transl Med"},{"key":"4120_CR7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ejmech.2016.06.017","volume":"121","author":"V Kumar","year":"2016","unstructured":"Kumar V, Islam A, Hassan MI, Ahmad F (2016) Therapeutic progress in amyotrophic lateral sclerosis-beginning to learning. Eur J Med Chem 121:903\u2013917","journal-title":"Eur J Med Chem"},{"key":"4120_CR8","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.bbadis.2016.06.011","volume":"1862","author":"V Kumar","year":"2016","unstructured":"Kumar V, Islam A, Hassan MI, Ahmad F (2016) Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: sequence and structure-based predictions. Biochimica et Biophysica Acta Mol Basis Dis 1862:1742\u20131754","journal-title":"Biochimica et Biophysica Acta Mol Basis Dis"},{"key":"4120_CR9","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/00207454.2017.1286339","volume":"127","author":"N Sami","year":"2017","unstructured":"Sami N, Rahman S, Kumar V, Zaidi S, Islam A, Ali S, Ahmad F, Hassan MI (2017) Protein aggregation, misfolding and consequential human neurodegenerative diseases. Int J Neurosci 127:1047\u20131057","journal-title":"Int J Neurosci"},{"key":"4120_CR10","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","volume":"14","author":"A As","year":"2018","unstructured":"As A (2018) 2018 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 14:367\u2013429","journal-title":"Alzheimers Dement"},{"key":"4120_CR11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molmed.2006.09.007","volume":"12","author":"A Wood-Kaczmar","year":"2006","unstructured":"Wood-Kaczmar A, Gandhi S, Wood N (2006) Understanding the molecular causes of Parkinson\u2019s disease. Trends Mol Med 12:521\u2013528","journal-title":"Trends Mol Med"},{"key":"4120_CR12","doi-asserted-by":"crossref","first-page":"a008888","DOI":"10.1101\/cshperspect.a008888","volume":"2","author":"C Klein","year":"2012","unstructured":"Klein C, Westenberger A (2012) Genetics of Parkinson\u2019s disease. Cold Spring Harb Perspect Med 2:a008888","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4120_CR13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neuron.2014.05.041","volume":"83","author":"CM Karch","year":"2014","unstructured":"Karch CM, Cruchaga C, Goate AM (2014) Alzheimer\u2019s disease genetics: from the bench to the clinic. Neuron 83:11\u201326","journal-title":"Neuron"},{"key":"4120_CR14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","volume":"72","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE, Hazrati L-N, Fujioka S, Wszolek ZK, Dickson DW, Ross OA, Van Deerlin VM, Trojanowski JQ, Hurtig HI (2015) Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72:100\u2013105","journal-title":"JAMA Neurol"},{"key":"4120_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro TF, Koss DJ, Erskine D, Walker L, Kurzawa-Akanbi M, Burn D, Donaghy P, Morris C, Taylor J-P, Thomas A (2019) Dementia with Lewy bodies: an update and outlook. Mol Neurodegener 14:1\u201318","journal-title":"Mol Neurodegener"},{"key":"4120_CR16","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ng.3043","volume":"46","author":"MA Nalls","year":"2014","unstructured":"Nalls MA, Pankratz N, Lill CM, Do CB, Hernandez DG, Saad M, DeStefano AL, Kara E, Bras J, Sharma M (2014) Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson\u2019s disease. Nat Genet 46:989\u2013993","journal-title":"Nat Genet"},{"key":"4120_CR17","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","volume":"18","author":"MA Nalls","year":"2019","unstructured":"Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A (2019) Identification of novel risk loci, causal insights, and heritable risk for Parkinson\u2019s disease: a meta-analysis of genome-wide association studies. Lancet Neurol 18:1091\u20131102","journal-title":"Lancet Neurol"},{"key":"4120_CR18","doi-asserted-by":"crossref","first-page":"10773","DOI":"10.1073\/pnas.1713969114","volume":"114","author":"SS Kang","year":"2017","unstructured":"Kang SS, Zhang Z, Liu X, Manfredsson FP, Benskey MJ, Cao X, Xu J, Sun YE, Ye K (2017) TrkB neurotrophic activities are blocked by \u03b1-synuclein, triggering dopaminergic cell death in Parkinson\u2019s disease. Proc Natl Acad Sci 114:10773\u201310778","journal-title":"Proc Natl Acad Sci"},{"key":"4120_CR19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.10846","volume":"55","author":"M Farrer","year":"2004","unstructured":"Farrer M, Kachergus J, Forno L, Lincoln S, Wang DS, Hulihan M, Maraganore D, Gwinn-Hardy K, Wszolek Z, Dickson D (2004) Comparison of kindreds with parkinsonism and \u03b1-synuclein genomic multiplications. Annal Neurol 55:174\u2013179","journal-title":"Annal Neurol"},{"key":"4120_CR20","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1126\/science.276.5321.2045","volume":"276","author":"MH Polymeropoulos","year":"1997","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R (1997) Mutation in the \u03b1-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045\u20132047","journal-title":"Science"},{"key":"4120_CR21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neulet.2017.12.001","volume":"672","author":"AB Pupyshev","year":"2018","unstructured":"Pupyshev AB, Korolenko TA, Akopyan AA, Amstislavskaya TG, Tikhonova MA (2018) Suppression of autophagy in the brain of transgenic mice with overexpression of A53T-mutant \u03b1-synuclein as an early event at synucleinopathy progression. Neurosci Lett 672:140\u2013144","journal-title":"Neurosci Lett"},{"key":"4120_CR22","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/humu.20507","volume":"28","author":"EK Tan","year":"2007","unstructured":"Tan EK, Skipper LM (2007) Pathogenic mutations in Parkinson disease. Hum Mutat 28:641\u2013653","journal-title":"Hum Mutat"},{"key":"4120_CR23","doi-asserted-by":"crossref","first-page":"e14228","DOI":"10.1097\/MD.0000000000014228","volume":"98","author":"Y-Q Fang","year":"2019","unstructured":"Fang Y-Q, Mao F, Zhu M-J, Li X-H (2019) Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease: a case report. Medicine 98:e14228","journal-title":"Medicine"},{"key":"4120_CR24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ana.10675","volume":"54","author":"PM Abou-Sleiman","year":"2003","unstructured":"Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW (2003) The role of pathogenic DJ-1 mutations in Parkinson\u2019s disease. Ann Neurol 54:283\u2013286","journal-title":"Ann Neurol"},{"key":"4120_CR25","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.1096284","volume":"304","author":"EM Valente","year":"2004","unstructured":"Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG (2004) Hereditary early-onset Parkinson\u2019s disease caused by mutations in PINK1. Science 304:1158\u20131160","journal-title":"Science"},{"key":"4120_CR26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-016-0009-6","volume":"8","author":"E Huang","year":"2017","unstructured":"Huang E, Qu D, Huang T, Rizzi N, Boonying W, Krolak D, Ciana P, Woulfe J, Klein C, Slack RS (2017) PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress. Nat Commun 8:1\u201311","journal-title":"Nat Commun"},{"key":"4120_CR27","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/ana.20484","volume":"57","author":"M Funayama","year":"2005","unstructured":"Funayama M, Hasegawa K, Ohta E, Kawashima N, Komiyama M, Kowa H, Tsuji S, Obata F (2005) An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family. Annal Neurol 57:918\u2013921","journal-title":"Annal Neurol"},{"key":"4120_CR28","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","volume":"36","author":"LA Volpicelli-Daley","year":"2016","unstructured":"Volpicelli-Daley LA, Abdelmotilib H, Liu Z, Stoyka L, Daher JPL, Milnerwood AJ, Unni VK, Hirst WD, Yue Z, Zhao HT (2016) G2019S-LRRK2 expression augments \u03b1-synuclein sequestration into inclusions in neurons. J Neurosci 36:7415\u20137427","journal-title":"J Neurosci"},{"key":"4120_CR29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/hmg\/ddx389","volume":"27","author":"APT Nguyen","year":"2018","unstructured":"Nguyen APT, Daniel G, Vald\u00e9s P, Islam MS, Schneider BL, Moore DJ (2018) G2019S LRRK2 enhances the neuronal transmission of tau in the mouse brain. Hum Mol Genet 27:120\u2013134","journal-title":"Hum Mol Genet"},{"key":"4120_CR30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.expneurol.2017.07.019","volume":"298","author":"AB West","year":"2017","unstructured":"West AB (2017) Achieving neuroprotection with LRRK2 kinase inhibitors in Parkinson disease. Exp Neurol 298:236\u2013245","journal-title":"Exp Neurol"},{"key":"4120_CR31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, Stefansson H, Sulem P, Gudbjartsson D, Maloney J (2012) A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature 488:96\u201399","journal-title":"Nature"},{"key":"4120_CR32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1471-4159.2011.07575.x","volume":"120","author":"A Goate","year":"2012","unstructured":"Goate A, Hardy J (2012) Twenty years of Alzheimer\u2019s disease-causing mutations. J Neurochem 120:3\u20138","journal-title":"J Neurochem"},{"key":"4120_CR33","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","volume":"34","author":"O'brien RJ and Wong PC,","year":"2011","unstructured":"O\u2019brien RJ and Wong PC, (2011) Amyloid precursor protein processing and Alzheimer\u2019s disease. Annu Rev Neurosci 34:185\u2013204","journal-title":"Annu Rev Neurosci"},{"key":"4120_CR34","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1073\/pnas.1619574114","volume":"114","author":"RJ Kelleher","year":"2017","unstructured":"Kelleher RJ, Shen J (2017) Presenilin-1 mutations and Alzheimer\u2019s disease. Proc Natl Acad Sci 114:629\u2013631","journal-title":"Proc Natl Acad Sci"},{"key":"4120_CR35","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1742-4658.2010.07566.x","volume":"277","author":"K Endres","year":"2010","unstructured":"Endres K, Fahrenholz F (2010) Upregulation of the \u03b1-secretase ADAM10\u2013risk or reason for hope? FEBS J 277:1585\u20131596","journal-title":"FEBS J"},{"key":"4120_CR36","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","volume":"13","author":"R Yan","year":"2014","unstructured":"Yan R, Vassar R (2014) Targeting the \u03b2 secretase BACE1 for Alzheimer\u2019s disease therapy. Lancet Neurol 13:319\u2013329","journal-title":"Lancet Neurol"},{"key":"4120_CR37","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3390\/biom10050789","volume":"10","author":"A Shamsi","year":"2020","unstructured":"Shamsi A, Anwar S, Mohammad T, Alajmi MF, Hussain A, Rehman M, Hasan GM, Islam A, Hassan M (2020) MARK4 inhibited by AChE inhibitors, donepezil and Rivastigmine tartrate: insights into Alzheimer\u2019s disease therapy. Biomolecules 10:789","journal-title":"Biomolecules"},{"key":"4120_CR38","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ijbiomac.2020.06.078","volume":"161","author":"S Anwar","year":"2020","unstructured":"Anwar S, Shamsi A, Kar RK, Queen A, Islam A, Ahmad F, Hassan MI (2020) Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: towards therapeutic implications in neurodegenerative diseases. Int J Biol Macromol 161:596\u2013604","journal-title":"Int J Biol Macromol"},{"key":"4120_CR39","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1089\/omi.2015.0111","volume":"19","author":"F Naz","year":"2015","unstructured":"Naz F, Shahbaaz M, Bisetty K, Islam A, Ahmad F, Hassan MI (2015) Designing new kinase inhibitor derivatives as therapeutics against common complex diseases: structural basis of microtubule affinity-regulating kinase 4 (MARK4) inhibition. Omics A J Integr Biol 19:700\u2013711","journal-title":"Omics A J Integr Biol"},{"key":"4120_CR40","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1080\/07391102.2019.1666745","volume":"38","author":"AAT Naqvi","year":"2020","unstructured":"Naqvi AAT, Jairajpuri DS, Noman OMA, Hussain A, Islam A, Ahmad F, Alajmi MF, Hassan MI (2020) Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: towards therapeutic management of Alzheimer\u2019s disease. J Biomol Struct Dyn 38:3892\u20133907","journal-title":"J Biomol Struct Dyn"},{"key":"4120_CR41","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s12013-013-9550-7","volume":"67","author":"F Naz","year":"2013","unstructured":"Naz F, Anjum F, Islam A, Ahmad F, Hassan MI (2013) Microtubule affinity-regulating kinase 4: structure, function, and regulation. Cell Biochem Biophys 67:485\u2013499","journal-title":"Cell Biochem Biophys"},{"key":"4120_CR42","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.1007\/s00018-017-2574-1","volume":"74","author":"N Annadurai","year":"2017","unstructured":"Annadurai N, Agrawal K, D\u017eub\u00e1k P, Hajd\u00fach M, Das V (2017) Microtubule affinity-regulating kinases are potential druggable targets for Alzheimer\u2019s disease. Cell Mol Life Sci 74:4159\u20134169","journal-title":"Cell Mol Life Sci"},{"key":"4120_CR43","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A (1998) Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702\u2013705","journal-title":"Nature"},{"key":"4120_CR44","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2174\/1568026620666200106125910","volume":"20","author":"AA Turab Naqvi","year":"2020","unstructured":"Turab Naqvi AA, Hasan GM, Hassan M (2020) Targeting tau hyperphosphorylation via kinase inhibition: strategy to address Alzheimer\u2019s disease. Curr Top Med Chem 20:1059\u20131073","journal-title":"Curr Top Med Chem"},{"key":"4120_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-38217-8","volume":"9","author":"M Voura","year":"2019","unstructured":"Voura M, Khan P, Thysiadis S, Katsamakas S, Queen A, Hasan GM, Ali S, Sarli V, Hassan MI (2019) Probing the inhibition of microtubule affinity regulating kinase 4 by N-substituted acridones. Sci Rep 9:1\u201317","journal-title":"Sci Rep"},{"key":"4120_CR46","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1080\/07391102.2016.1249958","volume":"35","author":"F Naz","year":"2017","unstructured":"Naz F, Sami N, Naqvi AT, Islam A, Ahmad F, Imtaiyaz Hassan M (2017) Evaluation of human microtubule affinity-regulating kinase 4 inhibitors: fluorescence binding studies, enzyme, and cell assays. J Biomol Struct Dyn 35:3194\u20133203","journal-title":"J Biomol Struct Dyn"},{"key":"4120_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-020-00410-7","volume":"15","author":"S Guha","year":"2020","unstructured":"Guha S, Fischer S, Johnson GV, Nehrke K (2020) Tauopathy-associated tau modifications selectively impact neurodegeneration and mitophagy in a novel C. elegans single-copy transgenic model. Mol Neurodegener 15:1\u201316","journal-title":"Mol Neurodegener"},{"key":"4120_CR48","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jsbmb.2016.03.012","volume":"160","author":"BC Riedel","year":"2016","unstructured":"Riedel BC, Thompson PM, Brinton RD (2016) Age, APOE and sex: triad of risk of Alzheimer\u2019s disease. J Steroid Biochem Mol Biol 160:134\u2013147","journal-title":"J Steroid Biochem Mol Biol"},{"key":"4120_CR49","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/aje\/kwv271","volume":"183","author":"SK Darweesh","year":"2016","unstructured":"Darweesh SK, Koudstaal PJ, Stricker BH, Hofman A, Ikram MA (2016) Trends in the incidence of Parkinson disease in the general population: the Rotterdam study. Am J Epidemiol 183:1018\u20131026","journal-title":"Am J Epidemiol"},{"key":"4120_CR50","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.ncl.2016.06.012","volume":"34","author":"A Lee","year":"2016","unstructured":"Lee A, Gilbert RM (2016) Epidemiology of Parkinson disease. Neurol Clin 34:955\u2013965","journal-title":"Neurol Clin"},{"key":"4120_CR51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/acel.12338","volume":"14","author":"VD Longo","year":"2015","unstructured":"Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, Curiel TJ, De Cabo R, Franceschi C, Gems D (2015) Interventions to slow aging in humans: are we ready? Aging Cell 14:497\u2013510","journal-title":"Aging Cell"},{"key":"4120_CR52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2147\/CLEP.S37929","volume":"6","author":"MM Mielke","year":"2014","unstructured":"Mielke MM, Vemuri P, Rocca WA (2014) Clinical epidemiology of Alzheimer\u2019s disease: assessing sex and gender differences. Clin Epidemiol 6:37","journal-title":"Clin Epidemiol"},{"key":"4120_CR53","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1161\/STROKEAHA.114.006571","volume":"46","author":"W Liu","year":"2015","unstructured":"Liu W, Wong A, Law AC, Mok VC (2015) Cerebrovascular disease, amyloid plaques, and dementia. Stroke 46:1402\u20131407","journal-title":"Stroke"},{"key":"4120_CR54","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2010.03329.x","volume":"18","author":"J De Reuck","year":"2011","unstructured":"De Reuck J, Deramecourt V, Cordonnier C, Leys D, Maurage C, Pasquier F (2011) The impact of cerebral amyloid angiopathy on the occurrence of cerebrovascular lesions in demented patients with Alzheimer features: a neuropathological study. Eur J Neurol 18:913\u2013918","journal-title":"Eur J Neurol"},{"key":"4120_CR55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/WCO.0b013e328341f8c0","volume":"24","author":"C Cordonnier","year":"2011","unstructured":"Cordonnier C (2011) Brain microbleeds: more evidence, but still a clinical dilemma. Curr Opin Neurol 24:69\u201374","journal-title":"Curr Opin Neurol"},{"key":"4120_CR56","first-page":"75","volume":"13","author":"ZY G\u00fcnayd\u0131n","year":"2016","unstructured":"G\u00fcnayd\u0131n ZY, \u00d6zer FF, Karag\u00f6z A, Bekta\u015f O, Karata\u015f MB, Vural A, Bayramo\u011flu A, \u00c7elik A, Yaman M (2016) Evaluation of cardiovascular risk in patients with Parkinson disease under levodopa treatment. JGC 13:75","journal-title":"JGC"},{"key":"4120_CR57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/CIA.S74042","volume":"10","author":"X Li","year":"2015","unstructured":"Li X, Song D, Leng SX (2015) Link between type 2 diabetes and Alzheimer\u2019s disease: from epidemiology to mechanism and treatment. Clin Interv Aging 10:549","journal-title":"Clin Interv Aging"},{"key":"4120_CR58","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00018-009-9070-1","volume":"66","author":"J G\u00f6tz","year":"2009","unstructured":"G\u00f6tz J, Ittner L, Lim Y-A (2009) Common features between diabetes mellitus and Alzheimer\u2019s disease. Cell Mol Life Sci 66:1321\u20131325","journal-title":"Cell Mol Life Sci"},{"key":"4120_CR59","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/dc10-1922","volume":"34","author":"Q Xu","year":"2011","unstructured":"Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A, Chen H (2011) Diabetes and risk of Parkinson\u2019s disease. Diabetes Care 34:910\u2013915","journal-title":"Diabetes Care"},{"key":"4120_CR60","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000496977","volume":"52","author":"J Chen","year":"2019","unstructured":"Chen J, Zhang C, Wu Y, Zhang D (2019) Association between hypertension and the risk of Parkinson\u2019s disease: a meta-analysis of analytical studies. Neuroepidemiology 52:181\u2013192","journal-title":"Neuroepidemiology"},{"key":"4120_CR61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-190474","volume":"71","author":"MJ Lennon","year":"2019","unstructured":"Lennon MJ, Makkar SR, Crawford JD, Sachdev PS (2019) Midlife hypertension and Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis 71:307\u2013316","journal-title":"J Alzheimers Dis"},{"key":"4120_CR62","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.expneurol.2009.09.013","volume":"223","author":"ACR Fonseca","year":"2010","unstructured":"Fonseca ACR, Resende R, Oliveira CR, Pereira CM (2010) Cholesterol and statins in Alzheimer\u2019s disease: current controversies. Exp Neurol 223:282\u2013293","journal-title":"Exp Neurol"},{"key":"4120_CR63","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1212\/01.wnl.0000271883.45010.8a","volume":"69","author":"KC Simon","year":"2007","unstructured":"Simon KC, Chen H, Schwarzschild M, Ascherio A (2007) Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 69:1688\u20131695","journal-title":"Neurology"},{"key":"4120_CR64","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1212\/WNL.0b013e318294b3c8","volume":"80","author":"G Pezzoli","year":"2013","unstructured":"Pezzoli G, Cereda E (2013) Exposure to pesticides or solvents and risk of Parkinson disease. Neurology 80:2035\u20132041","journal-title":"Neurology"},{"key":"4120_CR65","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nrneurol.2015.197","volume":"11","author":"L Klingelhoefer","year":"2015","unstructured":"Klingelhoefer L, Reichmann H (2015) Pathogenesis of Parkinson disease\u2014the gut\u2013brain axis and environmental factors. Nat Rev Neurol 11:625\u2013636","journal-title":"Nat Rev Neurol"},{"key":"4120_CR66","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/B978-0-7020-4087-0.00061-9","volume":"120","author":"E Reynolds","year":"2014","unstructured":"Reynolds E (2014) The neurology of folic acid deficiency. Handb Clin Neurol 120:927\u2013943","journal-title":"Handb Clin Neurol"},{"key":"4120_CR67","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3233\/JAD-150140","volume":"46","author":"L Shen","year":"2015","unstructured":"Shen L, Ji H-F (2015) Associations between homocysteine, folic acid, vitamin B12 and Alzheimer\u2019s disease: insights from meta-analyses. J Alzheimers Dis 46:777\u2013790","journal-title":"J Alzheimers Dis"},{"key":"4120_CR68","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrneurol.2013.132","volume":"9","author":"J Trinh","year":"2013","unstructured":"Trinh J, Farrer M (2013) Advances in the genetics of Parkinson disease. Nat Rev Neurol 9:445\u2013454","journal-title":"Nat Rev Neurol"},{"key":"4120_CR69","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.jad.2011.09.026","volume":"136","author":"JM Garc\u00eda-Alberca","year":"2012","unstructured":"Garc\u00eda-Alberca JM, Cruz B, Lara JP, Garrido V, Gris E, Lara A, Castilla C (2012) Disengagement coping partially mediates the relationship between caregiver burden and anxiety and depression in caregivers of people with Alzheimer\u2019s disease. Results from the M\u00c1LAGA-AD study. J Affect Disord 136:848\u2013856","journal-title":"J Affect Disord"},{"key":"4120_CR70","first-page":"1","volume":"8","author":"Z Zhou","year":"2018","unstructured":"Zhou Z, Wang P, Fang Y (2018) Social engagement and its change are associated with dementia risk among Chinese older adults: a longitudinal study. Sci Rep 8:1\u20137","journal-title":"Sci Rep"},{"key":"4120_CR71","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/aje\/kwj061","volume":"163","author":"JS Saczynski","year":"2006","unstructured":"Saczynski JS, Pfeifer LA, Masaki K, Korf ES, Laurin D, White L, Launer LJ (2006) The effect of social engagement on incident dementia: the Honolulu-Asia aging study. Am J Epidemiol 163:433\u2013440","journal-title":"Am J Epidemiol"},{"key":"4120_CR72","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.trci.2018.04.001","volume":"4","author":"H Topiwala","year":"2018","unstructured":"Topiwala H, Terrera GM, Stirland L, Saunderson K, Russ TC, Dozier MF, Ritchie CW (2018) Lifestyle and neurodegeneration in midlife as expressed on functional magnetic resonance imaging: a systematic review. Alzheimer\u2019s Dementia Transl Res Clin Interven 4:182\u2013194","journal-title":"Alzheimer\u2019s Dementia Transl Res Clin Interven"},{"key":"4120_CR73","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/ana.24385","volume":"77","author":"RB Postuma","year":"2015","unstructured":"Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, Miyamoto T, Oertel W, Dauvilliers Y, Ju YE (2015) Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Ann Neurol 77:830\u2013839","journal-title":"Ann Neurol"},{"key":"4120_CR74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/BPL-180071","volume":"4","author":"A Fernandez","year":"2018","unstructured":"Fernandez A, Santi A, Torres Aleman I (2018) Insulin peptides as mediators of the impact of life style in Alzheimer\u2019s disease. Brain Plasticity 4:3\u201315","journal-title":"Brain Plasticity"},{"key":"4120_CR75","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/ern.11.56","volume":"11","author":"V Solfrizzi","year":"2011","unstructured":"Solfrizzi V, Panza F, Frisardi V, Seripa D, Logroscino G, Imbimbo BP, Pilotto A (2011) Diet and Alzheimer\u2019s disease risk factors or prevention: the current evidence. Expert Rev Neurother 11:677\u2013708","journal-title":"Expert Rev Neurother"},{"key":"4120_CR76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0000000000004057","volume":"89","author":"KC Hughes","year":"2017","unstructured":"Hughes KC, Gao X, Kim IY, Wang M, Weisskopf MG, Schwarzschild MA, Ascherio A (2017) Intake of dairy foods and risk of Parkinson disease. Neurology 89:46\u201352","journal-title":"Neurology"},{"key":"4120_CR77","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.3233\/JAD-2010-091525","volume":"20","author":"J Costa","year":"2010","unstructured":"Costa J, Lunet N, Santos C, Santos J, Vaz-Carneiro A (2010) Caffeine exposure and the risk of Parkinson\u2019s disease: a systematic review and meta-analysis of observational studiess. J Alzheimers Dis 20:S221\u2013S238","journal-title":"J Alzheimers Dis"},{"key":"4120_CR78","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1001\/jamapsychiatry.2017.2816","volume":"74","author":"A Terracciano","year":"2017","unstructured":"Terracciano A, An Y, Sutin AR, Thambisetty M, Resnick SM (2017) Personality change in the preclinical phase of Alzheimer disease. JAMA Psychiatry 74:1259\u20131265","journal-title":"JAMA Psychiatry"},{"key":"4120_CR79","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jalz.2013.03.002","volume":"10","author":"A Terracciano","year":"2014","unstructured":"Terracciano A, Sutin AR, An Y, O\u2019Brien RJ, Ferrucci L, Zonderman AB, Resnick SM (2014) Personality and risk of Alzheimer\u2019s disease: new data and meta-analysis. Alzheimers Dement 10:179\u2013186","journal-title":"Alzheimers Dement"},{"key":"4120_CR80","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10654-015-0062-1","volume":"31","author":"J Sieurin","year":"2016","unstructured":"Sieurin J, Gustavsson P, Weibull CE, Feldman AL, Petzinger GM, Gatz M, Pedersen NL, Wirdefeldt K (2016) Personality traits and the risk for Parkinson disease: a prospective study. Eur J Epidemiol 31:169\u2013175","journal-title":"Eur J Epidemiol"},{"key":"4120_CR81","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/jcpe.13016","volume":"45","author":"J Holmer","year":"2018","unstructured":"Holmer J, Eriksdotter M, Schultzberg M, Pussinen PJ, Buhlin K (2018) Association between periodontitis and risk of Alzheimer\u2019s disease, mild cognitive impairment and subjective cognitive decline: a case\u2013control study. J Clin Periodontol 45:1287\u20131298","journal-title":"J Clin Periodontol"},{"key":"4120_CR82","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000277456.29440.16","volume":"69","author":"T Ngandu","year":"2007","unstructured":"Ngandu T, von Strauss E, Helkala E-L, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M (2007) Education and dementia: what lies behind the association? Neurology 69:1442\u20131450","journal-title":"Neurology"},{"key":"4120_CR83","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1159\/000227781","volume":"27","author":"H Bickel","year":"2009","unstructured":"Bickel H, Kurz A (2009) Education, occupation, and dementia: the Bavarian school sisters study. Dement Geriatr Cogn Disord 27:548\u2013556","journal-title":"Dement Geriatr Cogn Disord"},{"key":"4120_CR84","unstructured":"Hsieh SH (2020) Depression in Parkinson\u2019s disease. In: UCLA"},{"key":"4120_CR85","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1007\/s12035-016-0046-5","volume":"54","author":"N Sami","year":"2017","unstructured":"Sami N, Kumar V, Islam A, Ali S, Ahmad F, Hassan I (2017) Exploring missense mutations in tyrosine kinases implicated with neurodegeneration. Mol Neurobiol 54:5085\u20135106","journal-title":"Mol Neurobiol"},{"key":"4120_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/8363245","volume":"2020","author":"P Hrelia","year":"2020","unstructured":"Hrelia P, Sita G, Ziche M, Ristori E, Marino A, Cordaro M, Molteni R, Spero V, Malaguti M, Morroni F (2020) Common protective strategies in neurodegenerative disease: focusing on risk factors to target the cellular redox system. Oxid Med Cell Longev 2020:1\u201318","journal-title":"Oxid Med Cell Longev"},{"key":"4120_CR87","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3389\/fphar.2018.01192","volume":"9","author":"TCD Santos","year":"2018","unstructured":"Santos TCD, Gomes TM, Pinto BAS, Camara AL, Paes AMdA (2018) Naturally occurring acetylcholinesterase inhibitors and their potential use for Alzheimer\u2019s disease therapy. Front Pharmacol 9:1192","journal-title":"Front Pharmacol"},{"key":"4120_CR88","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","volume":"41","author":"C-C Tan","year":"2014","unstructured":"Tan C-C, Yu J-T, Wang H-F, Tan M-S, Meng X-F, Wang C, Jiang T, Zhu X-C, Tan L (2014) Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis. J Alzheimers Dis 41:615\u2013631","journal-title":"J Alzheimers Dis"},{"key":"4120_CR89","first-page":"495","volume-title":"Diagnosis and management in dementia","author":"G Marucci","year":"2010","unstructured":"Marucci G, Moruzzi M, Amenta F (2010) Donepezil in the treatment of Alzheimer\u2019s disease. Diagnosis and management in dementia. Elsevier, Amsterdam, pp 495\u2013510"},{"key":"4120_CR90","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S1474-4422(12)70152-7","volume":"11","author":"P Svenningsson","year":"2012","unstructured":"Svenningsson P, Westman E, Ballard C, Aarsland D (2012) Cognitive impairment in patients with Parkinson\u2019s disease: diagnosis, biomarkers, and treatment. Lancet Neurol 11:697\u2013707","journal-title":"Lancet Neurol"},{"key":"4120_CR91","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.25098","volume":"27","author":"B Dubois","year":"2012","unstructured":"Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J (2012) Donepezil in Parkinson\u2019s disease dementia: a randomized, double-blind efficacy and safety study. Mov Disord 27:1230\u20131238","journal-title":"Mov Disord"},{"key":"4120_CR92","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/mds.25870","volume":"29","author":"M Emre","year":"2014","unstructured":"Emre M, Ford PJ, Bilgi\u00e7 B, U\u00e7 EY (2014) Cognitive impairment and dementia in Parkinson\u2019s disease: practical issues and management. Mov Disord 29:663\u2013672","journal-title":"Mov Disord"},{"key":"4120_CR93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41398-018-0162-2","volume":"8","author":"B Vanle","year":"2018","unstructured":"Vanle B, Olcott W, Jimenez J, Bashmi L, Danovitch I, IsHak WW (2018) NMDA antagonists for treating the non-motor symptoms in Parkinson\u2019s disease. Transl Psychiatry 8:1\u201315","journal-title":"Transl Psychiatry"},{"key":"4120_CR94","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1021\/acschemneuro.7b00270","volume":"8","author":"S Alam","year":"2017","unstructured":"Alam S, Lingenfelter KS, Bender AM, Lindsley CW (2017) Classics in chemical neuroscience: memantine. ACS Chem Neurosci 8:1823\u20131829","journal-title":"ACS Chem Neurosci"},{"key":"4120_CR95","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41586-018-0039-9","volume":"556","author":"X Song","year":"2018","unstructured":"Song X, Jensen M\u00d8, Jogini V, Stein RA, Lee C-H, Mchaourab HS, Shaw DE, Gouaux E (2018) Mechanism of NMDA receptor channel block by MK-801 and memantine. Nature 556:515\u2013519","journal-title":"Nature"},{"key":"4120_CR96","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1570159X14666151120123025","volume":"14","author":"J Dong","year":"2016","unstructured":"Dong J, Cui Y, Li S, Le W (2016) Current pharmaceutical treatments and alternative therapies of Parkinson\u2019s disease. Curr Neuropharmacol 14:339\u2013355","journal-title":"Curr Neuropharmacol"},{"key":"4120_CR97","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005562.pub2","author":"B Woods","year":"2012","unstructured":"Woods B, Aguirre E, Spector AE, Orrell M (2012) Cognitive stimulation to improve cognitive functioning in people with dementia. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD005562.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"4120_CR98","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1586\/14737175.8.5.751","volume":"8","author":"A Spector","year":"2008","unstructured":"Spector A, Woods B, Orrell M (2008) Cognitive stimulation for the treatment of Alzheimer\u2019s disease. Expert Rev Neurother 8:751\u2013757","journal-title":"Expert Rev Neurother"},{"key":"4120_CR99","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3389\/fnhum.2015.00130","volume":"9","author":"F Angelucci","year":"2015","unstructured":"Angelucci F, Peppe A, Carlesimo GA, Serafini F, Zabberoni S, Barban F, Shofany J, Caltagirone C, Costa A (2015) A pilot study on the effect of cognitive training on BDNF serum levels in individuals with Parkinson\u2019s disease. Front Hum Neurosci 9:130","journal-title":"Front Hum Neurosci"},{"key":"4120_CR100","first-page":"17","volume":"4","author":"ME Hackney","year":"2014","unstructured":"Hackney ME, Bennett CG (2014) Dance therapy for individuals with Parkinson\u2019s disease: improving quality of life. Res Rev Parkinsonism 4:17\u201325","journal-title":"Res Rev Parkinsonism"},{"key":"4120_CR101","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jbmt.2020.06.032","volume":"26","author":"S Lihala","year":"2020","unstructured":"Lihala S, Mitra S, Neogy S, Datta N, Choudhury S, Chatterjee K, Mondal B, Halder S, Roy A, Sengupta M (2020) Dance movement therapy in rehabilitation of Parkinson\u2019s disease\u2013a feasibility study. J Bodywork Mov Ther 26:12\u201317","journal-title":"J Bodywork Mov Ther"},{"key":"4120_CR102","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-017-0073-9","volume":"6","author":"R Fang","year":"2017","unstructured":"Fang R, Ye S, Huangfu J, Calimag DP (2017) Music therapy is a potential intervention for cognition of Alzheimer\u2019s disease: a mini-review. Transl Neurodegener 6:1\u20138","journal-title":"Transl Neurodegener"},{"key":"4120_CR103","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0891988718819858","volume":"32","author":"APS Pereira","year":"2019","unstructured":"Pereira APS, Marinho V, Gupta D, Magalh\u00e3es F, Ayres C, Teixeira S (2019) Music therapy and dance as gait rehabilitation in patients with Parkinson disease: a review of evidence. J Geriatr Psychiatry Neurol 32:49\u201356","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"4120_CR104","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/00222895.2016.1241739","volume":"49","author":"G Lamotte","year":"2017","unstructured":"Lamotte G, Shah RC, Lazarov O, Corcos DM (2017) Exercise training for persons with Alzheimer\u2019s disease and caregivers: a review of dyadic exercise interventions. J Mot Behav 49:365\u2013377","journal-title":"J Mot Behav"},{"key":"4120_CR105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12877-018-0864-6","volume":"18","author":"Y Duan","year":"2018","unstructured":"Duan Y, Lu L, Chen J, Wu C, Liang J, Zheng Y, Wu J, Rong P, Tang C (2018) Psychosocial interventions for Alzheimer\u2019s disease cognitive symptoms: a Bayesian network meta-analysis. BMC Geriatr 18:1\u201311","journal-title":"BMC Geriatr"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04120-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-021-04120-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-021-04120-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T07:46:36Z","timestamp":1623311196000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-021-04120-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":105,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["4120"],"URL":"https:\/\/doi.org\/10.1007\/s11010-021-04120-6","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]},"assertion":[{"value":"19 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}